Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Philadelphia, PA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Philadelphia, PA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Lincoln, RI
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lincoln, RI
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Charleston, SC
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Memphis, TN
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Memphis, TN
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Austin, TX
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Desoto, TX
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Desoto, TX
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Houston, TX
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Houston, TX
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
San Antonio, TX
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Wichita Falls, TX
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Clinton, UT
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Clinton, UT
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Woodstock, VT
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Woodstock, VT
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Bellevue, WA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Seattle, WA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Spokane, WA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Middleton, WI
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Middleton, WI
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Waukesha, WI
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Waukesha, WI
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Bellflower, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Bellflower, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
The Villages, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
The Villages, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Deerfield, IL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Deerfield, IL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Towong,
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Towong,
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Belmont, MA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Belmont, MA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Saint Charles, MO
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Saint Charles, MO
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Sugar Land, TX
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 010
mi
from
Birmingham, AL
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 010
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 055
mi
from
Dothan, AL
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 055
mi
from
Dothan, AL
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Phoenix, AZ
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site #023
mi
from
Beverly Hills, CA
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site #023
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 047
mi
from
Chino, CA
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 047
mi
from
Chino, CA
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 010
mi
from
Costa Mesa, CA
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site #017
mi
from
Encino, CA
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site #017
mi
from
Encino, CA
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Oceanside, CA
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 043
mi
from
Simi Valley, CA
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 043
mi
from
Simi Valley, CA
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Cromwell, CT
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Cromwell, CT
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 026
mi
from
Norwich, CT
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 026
mi
from
Norwich, CT
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 001
mi
from
Bradenton, FL
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 001
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site #015
mi
from
Fort Myers, FL
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site #015
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 08
mi
from
Jacksonville Beach, FL
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 08
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 1543
mi
from
Jacksonville, FL
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 1543
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Kissimmee, FL
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Kissimmee, FL
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 061
mi
from
Orlando, FL
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 061
mi
from
Orlando, FL
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 032
mi
from
West Palm Beach, FL
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 032
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 034
mi
from
Alpharetta, GA
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 034
mi
from
Alpharetta, GA
Click here to add this to my saved trials